"For nearly 50 years, the board certified ophthalmologists, optometrists, and opticians at Eye Care Specialists have provided for the eye care needs of Northeastern Pennsylvania. Our eye doctors are pioneers in the field of ophthalmology; they have collectively performed more than 50,000 successful cataract surgeries and have more than 550 years of combined experience in treating eye disorders."

During the past decade, Eye Care Specialists conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 6 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eye Care Specialists" #1 sponsor was "Johns Hopkins University" with 3 trials, followed by "Aqumen Biopharmaceuticals, N.A." with 2 trials sponsored, "Formosa Pharmaceuticals, Inc." with 2 trials sponsored, "Johnson & Johnson Surgical Vision, Inc." with 2 trials sponsored and "Kala Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eye Care Specialists" #1 collaborator was "Juvenile Diabetes Research Foundation" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Eye Care Specialists" are "Diabetic Macular Edema" (5 trials), "Cataract" (3 trials), "Mature Cataracts" (2 trials), "Bacterial Infections" (1 trials) and "Cataract Extraction" (1 trials). Many other conditions were trialed in "Eye Care Specialists" in a lesser frequency.

Most popular intervention types in "Eye Care Specialists" are "Drug" (18 trials), "Device" (5 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (4 trials), "Placebo" (3 trials), "APP13007, 0.05%" (2 trials), "Aflibercept" (2 trials) and "DYME" (2 trials). Other intervention names were less common.

The vast majority of trials in "Eye Care Specialists" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Eye Care Specialists". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Eye Care Specialists, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Eye Care Specialists, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".